Lilium Announces Pricing of $114 Million Financing
Lilium has announced the pricing of a $114 million financing, which includes a $40 million public offering and a $50 million private placement. The financing involves the sale of Class A ordinary shares and accompanying warrants to purchase additional shares. Major investors include BIT Capital, Earlybird Venture Capital, and Aceville Pte. , an affiliate of Tencent Holdings. The funds will support Lilium's development and operations, with an emphasis on progressing towards the first manned flight of the Lilium Jet in late 2024. The public offering is expected to close on May 29, 2024, while the private placement will close in two stages on May 31, 2024, and June 28, 2024. B. Riley Securities serves as the sole bookrunner for the public offering.
- Secured $114 million in financing.
- Key investors include BIT Capital, Earlybird Venture Capital, Aceville (Tencent Holdings).
- Financing supports development and operations, particularly towards first manned flight of Lilium Jet in late 2024.
- Public offering expected to close on May 29, 2024, and private placement to close in two stages on May 31, 2024, and June 28, 2024.
- Participation from existing shareholders and company insiders shows strong internal confidence.
- Dilution of shares due to issuance of new Class A ordinary shares and accompanying warrants.
- Potential for shareholder approval delays impacting the increase in authorized share capital.
- Public offering price set at $1.05 per share might be considered low by some investors.
- Exercise price of $1.50 per warrant could be seen as a potential overhang on the stock.
Insights
The
The pricing of shares at
This financing helps bolster Lilium's balance sheet, providing the necessary liquidity to continue its development. Investors should monitor how these funds are allocated, specifically towards R&D and operational milestones.
It's also critical to observe how the stock market reacts to this announcement, as it often reflects investor sentiment more broadly than individual participation can.
Lilium's financing initiative aligns with broader trends in the Regional Air Mobility (RAM) and eVTOL sectors. The significant involvement from notable investors such as BIT Capital, Earlybird Venture Capital and Tencent's affiliate Aceville underscores the growing interest in sustainable and next-generation transportation technologies.
From a market perspective, this financing positions Lilium to advance in a highly competitive field. The company's unique value proposition lies in its all-electric vertical take-off and landing jet, which distinguishes it from traditional aviation solutions. The target of a first manned flight by late 2024 sets a clear milestone that can serve as a catalyst for investor enthusiasm if achieved.
However, the competitive landscape is fierce, with other players also vying for a slice of the emerging RAM market. Therefore, investors should keep a close eye on Lilium's technological advancements, regulatory approvals and strategic partnerships, which will be important for maintaining its competitive edge.
The long-term potential for Lilium hinges on its ability to demonstrate reliable and scalable technology that meets regulatory standards and market demands.
Financing sees meaningful participation from existing shareholders and company insiders, propelling Lilium towards first manned flight of the Lilium Jet targeted for late 2024
MUNICH, Germany, May 24, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM) (“Lilium” or the “Company”), developer of the first all-electric vertical take-off and landing (“eVTOL”) jet and global pioneer in Regional Air Mobility (RAM), announced a
In connection with the underwritten public offering, the price of the 38,095,238 Shares and accompanying Warrants being sold to the public is
The Securities being offered pursuant to the underwritten public offering are being offered pursuant to a shelf registration statement on Form F-3 (File No. 333-267719) previously filed with the U.S. Securities and Exchange Commission (the “SEC”), which the SEC declared effective on October 12, 2022. A preliminary prospectus supplement related to the underwritten public offering was filed with the SEC on May 23, 2024, and a final prospectus supplement will be filed with the SEC. The preliminary prospectus supplement is and the final prospectus supplement will be available on the SEC’s website located at http://www.sec.gov or may be obtained from B. Riley Securities, Inc., Attention: Prospectus Department, 1300 North 17th Street, Suite 1300, Arlington, Virginia 22209; Telephone: (703) 312-9580, or by emailing prospectuses@brileyfin.com.
In connection with the concurrent PIPE, the Company entered into securities purchase agreements with a number of investors including BIT Capital, Earlybird Venture Capital and Aceville, as well as certain Lilium board members, for the purchase and sale of an aggregate of 47,573,111 Shares and warrants to purchase 47,573,111 Shares for
The Company intends to use the net proceeds from the underwritten public offering, the PIPE and the Aceville Pre-Funding to continue to fund the development and operations of the Company and for general corporate purposes.
The public offering is expected to close on May 29¸ 2024, approximately
Neither the underwritten public offering nor the PIPE is conditional on the other. The securities are being issued pursuant to the exemptions provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Regulation S, have not been registered under the Securities Act or any state or other applicable jurisdiction’s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdiction’s securities laws.
This press release does not constitute an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of the Shares or warrants in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Contact Information for Media:
Rainer Ohler
+49 172 4890353
press@lilium.com
Contact Information for Investors:
Rama Bondada
Vice President, Investor Relations
investors@lilium.com
About Lilium
Lilium (NASDAQ: LILM) is creating a sustainable and accessible mode of high-speed, regional transportation for people and goods. Using the Lilium Jet, an all-electric vertical take-off and landing jet, designed to offer leading capacity, low noise, and high performance with zero operating emissions, Lilium is accelerating the decarbonization of air travel. Working with aerospace, technology, and infrastructure leaders, and with announced sales and indications of interest in Europe, the United States, China, Brazil, the UK, the United Arab Emirates, and the Kingdom of Saudi Arabia, Lilium’s 1000+ strong team includes approximately 500 aerospace engineers and a leadership team responsible for delivering some of the most successful aircraft in aviation history. Founded in 2015, Lilium’s headquarters and manufacturing facilities are in Munich, Germany, with teams based across Europe and the U.S. To learn more, visit www.lilium.com.
Important information
No announcements or information regarding the underwritten public offering may be disseminated to the public in jurisdictions where a prior registration or approval is required for such purpose. No steps have been taken, or will be taken, for the offering of the Shares of the warrants in any jurisdiction where such steps would be required. The issue or sale of the Shares and the warrants, and the subscription for or purchase of the Shares and the warrants, are subject to special legal or statutory restrictions in certain jurisdictions. Lilium is not liable if these restrictions are not complied with by any other person.
This press release is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (the “Prospectus Regulation”) and has not been approved by any regulatory authority in any jurisdiction. Lilium has not authorized any offer to the public of the Shares or the warrants in any member state of the European Economic Area (“EEA”) and no prospectus has been or will be prepared in connection therewith. In any EEA member state, this communication is only addressed to and is only directed at qualified investors in that member state within the meaning of the Prospectus Regulation.
In the United Kingdom, this document and any other materials in relation to the Shares and the warrants described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” who are (i) persons having professional experience in matters relating to investments who fall within the definition of “investment professionals” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). In the United Kingdom, any investment or investment activity to which this communication relates is available only to, and will be engaged in only with, relevant persons. Persons who are not relevant persons should not take any action on the basis of this document and should not act or rely on it.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the U.S. federal securities laws, including, but not limited to, the expected closing of the underwritten public offering, the PIPE and the Aceville Pre-Funding described herein and the use of proceeds therefrom. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “expect,” “estimate,” “future,” “intend,” “may,” “plan,” “project,” “should,” “strategy,” “will,” “would” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on management’s current expectations with respect to future events and are based on assumptions and are subject to risks and uncertainties that are subject to change at any time. Actual events or results may differ materially from those contained in the forward-looking statements. Factors that could cause actual future events to differ materially from the forward-looking statements in this press release include the risk that the offerings described herein are not consummated on a timely basis or at all as well as those risks and uncertainties discussed in Lilium’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including in the section titled “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2023, on file with the SEC, and similarly titled sections in Lilium’s other SEC filings, all of which are available at www.sec.gov. We caution investors not to rely on the forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC available at www.sec.gov for a discussion of these and other risks or uncertainties. Forward-looking statements speak only as of the date they are made. You are cautioned not to put undue reliance on forward-looking statements, and Lilium assumes no obligation to, and does not intend to, update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Lilium’s business is subject to substantial risks and uncertainties including those described in Lilium’s filings with the SEC referenced above. Investors, potential investors and others should give careful consideration to these risks and uncertainties.
FAQ
What is the amount of financing Lilium announced?
When is the first manned flight of the Lilium Jet targeted?
Who are the major investors in Lilium's financing?
What is the pricing of the public offering in Lilium's financing round?
When are the closing dates for Lilium's financing tranches?
What will Lilium use the financing proceeds for?
